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Abstract 
Primitive neuroectodermal tumors are among the most common tumors of childhood and the 
most frequent location of them is cerebellum. Supratentorial primitive neuroectodermal 
tumors are uncommon. These tumors, regardless of site of origin, may show differentiations 
towards different cell lines such as glial, neuronal, and mesenchymal. To our knowledge, 
there is only one case in the literature describing ganglioglial differentiation in a cerebellar 
medulloblastoma. The presented report discloses a supratentorial primitive neuroectodermal 
tumor coexistent with anaplastic ganglioglioma in a 46-year-old man. Both components of the 
tumor disappeared after radiotherapy, with a proceedent glioblastomatous differentiation in 
the follow-up period. 
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Introduction   
“Primitive neuroectodermal tumors” are among the most common tumors of childhood and 
are frequently located in cerebellum. These tumors, regardless of site of origin, may contain 
cells displaying features of neoplastic astrocytes, oligodendrocytes, ependymal cells, neuronal 
cells, melanocytes, or mesenchymal cells, such as smooth or striated muscle [1]. To our 
knowledge, there is only one case in the literature describing ganglioglial differentiation in a 
cerebellar medulloblastoma [2]. A supratentorial primitive neuroectodermal tumor (S-PNET) 
coexistent with anaplastic ganglioglioma in an adult which both components disappeared and 





A 46-year-old man with the major complaint of somnolence for twenty days was admitted to 
the neurosurgery department. History revealed alcohol addiction for twenty years. Physical 
examination did not reveal any data of interest except for cachectic appearance. Somnolence, 
loss of orientation, and poor plantar responses bilaterally were detected in neurologic 
examination. Laboratory findings were in normal ranges.  
 
Fig. 1: a-Contrasted cranial axial CT showing cystic and solid tumor revealing enhancement 
in the solid area.  b-T1-weighted contrasted coronal MRI showing solid-cystic lesion reaching 
the interhemispheric fissura in the right frontal region.  c-T1-weighted contrasted axial MRI 
showing the enhanced tumor compressing the right frontal horn.  d-T1-weighted contrasted 
sagittal MRI showing solid-cystic lesion in the frontal area. 
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Computed tomography (CT) of the brain revealed a 5x4x3 cm, partially hypo and partially 
iso-hyperdense lesion which was interpreted as solid and cystic components with contrast 
enhancement and right frontal horn compression. Magnetic Resonance Imaging (MRI) 
confirmed the CT appearance (Fig.1a-1d). The patient underwent surgery with the suspected 
diagnoses of high grade glial tumor, abscess or metastasis. A microsurgical gross total 
excision was performed.  
Macroscopically the specimen was composed of multiple fragments of tissue of 30 cc volume. 
They were soft and greyish white to brown colored. Histologically it was a tumor partially 
composed of glial cells with hyperchromatic and pleomorphic nuclei showing hypercellularity 
with accompanying gemistocytes and atypical neuronal cells (Fig.2a). The other component 
was a tumor composed of closely packed cells with hyperchromatic, oval and carrot-shaped 
nuclei and indistinct cytoplasm. Cells formed rosettes in these areas (Fig.2b). The stroma in 
both components of the tumor was fibrillary. Wide necrotic areas were also detected. Both 
components were mitotically active.  
 
Fig. 2: a-Pleomorphic glial cells with hyperchromatic nuclei and atypical neuronal cells (H.E. 
x 100).  b-The rosette formations (arrow) made by cells with hyperchromatic, ovoid-carrot 
shaped nuclei and indistinct cytoplasm on the fibrillary ground (H.E. x 200). 
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Immunohistochemically the anaplastic ganglioglial component of the tumor was positive for 
glial fibrillary acidic protein (GFAP) (Fig.3a), S-100 protein, and vimentin. The atypical 
neuronal cells were positive for chromogranin A (Fig.3b) and neurofilament (Fig.3c). The 
second component of the tumor was negative for all these markers, but positive for neuron 
specific enolase (NSE). 
 
Fig.3: a-Anaplastic ganglioglial component showing GFAP positivity. Note that PNET 
component is negative for GFAP (GFAP x 100). b-Chromogranin positivity in atypical 
neuronal cells (Chromogranin A x 200). c- Atypical neuronal cells showing neurofilament 
positivity (Neurofilament x 150). 
 
In the light of all these findings ‘a composite tumor including anaplastic ganglioglioma and S-
PNET’ was diagnosed. Radiotherapy was instituted and control CT of the brain six months 
after the surgery showed a lesion with heterogenous contrast enhancement in the right frontal 
region which suggested a recurrent tumor. Cranial T1-weighted axial and sagittal contrasted 
MRI revealed a lesion with heterogenous conrast enhancement disclosing dural invasion and 
mass effect.  The patient was subsequently re-operated on and gross total mass excision was 
performed. Macroscopically the specimen was composed of soft, greyish white to brown 
colored tissue fragments with 23 cc volume. Histologically a tumor composed of pleomorphic 
cells showing distinct microvascular proliferation and necrosis was detected (Fig.4). The 
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tumor was positive for GFAP immunohistochemically. The final diagnosis was glioblastoma 
multiforme. The patient was discharged without any complication and chemotherapy was 
proposed. The patient denied chemotherapeutic regimen. His follow-up examination twenty-
two months after the first operation was within normal limits. The patient referred to the 
emergency department two months later with a recurrent intracranial mass. Further therapy 
was rejected and the patient expired within a month. 
 




S-PNET is an uncommon embryonal tumor of cerebral hemispheres or suprasellar region 
composed of undifferentiated or poorly differentiated neuroepithelial cells which have the 
capacity for or display divergent differentiation along neuronal, astrocytic, ependymal, 
muscular or melanocytic lines, as defined by the World Health Organization (WHO). It 
corresponds histologically to WHO grade IV [3]. The term PNET which was first described 
by Hart and Earle in 1973 has been widely used for a group of morphologically similar 
tumors in both the central and peripheral nervous systems [4,5]. S-PNETs primarily occur in 
children [4,6,7], ranging between the ages of  4 weeks to 10 years, with a mean of 5.5 years 
Medicine Science. 2012;1(1):47-54                                                                 Composite tumor 
www.medicinescience.org | Med-Science 52 
 
[3]. They are most commonly located in the hemispheres [4]. They are highly malignant 
tumors with a rapid course to death and their survivals range between 7-24 months [4]. Light 
microscopic features of S-PNETs are basically similar to cerebellar medulloblastoma 
[1,3,6,7]. It is stated that tumors identical in appearance to medulloblastoma might arise in 
retina, pineal gland, cerebrum, or spinal cord, and their biologic behaviour is similar [1,8]. So 
they are indistinguishable by histology alone if their location is unknown, and named under 
the name of PNET. Rorke et al commented that a simple description of the recognizable types 
within these tumors (e.g. PNET with astrocytes) would be more acceptable than an 
interpretive diagnosis such as  “PNET with astrocytic differentiation” [1].  
Evidence of divergent differentiation in cells is most reliably identified by use of various 
antibodies such as GFAP, neurofilament protein and desmin [3]. The histogenesis of PNETs 
as a group is still  controversial [3,6,7], and the only issue upon which consensus has been 
achieved is that these embryonal tumors arise from primitive neuroepithelial cells regardless 
of their location [3]. 
Pearl et al reported a supratentorial glioblastoma that occurred 13 years after radiation therapy 
for a cerebellar medulloblastoma. They commented that the diverse ultrastructural features of 
the glioblastoma might reflect the multipotentiality of the cells in medulloblastoma, or 
alternatively, the glioblastoma represented a radiation-induced neoplasm after therapy for a 
medulloblastoma [9]. Though Bhangui et al reported a synchronous occurrence of optic nerve 
glioma, a pilocytic astrocytoma, a ganglioglioma and a medulloblastoma in a 12-year-old girl, 
the tumors in their case were located in different sites of the brain. So, they were multiple 
primary tumors, but not a composite tumor [10]. 
To our knowledge, the presented case is the first composite tumor including anaplastic 
ganglioglioma and S-PNET recurring as glioblastoma in the literature. Ganglioglial 
differentiation in a medulloblastoma was reported by Kudo et al, but the ganglioglial 
component was benign and its localization was cerebellum in their case [2]. It is also a rare 
occurrence that the patient presented here is in his fifth decade for PNETs most commonly 
occur in children [3,6,7]. 
The prognosis is poorer in infants with PNET who are less than two years old at the time of 
diagnosis. While 5-year survival rate for the patients with S-PNETs is 34%, it is reported to 
be as high as 85% for the ones with a PNET arising in the posterior fossa [3]. Neither the 
GFAP-positivity nor the neuronal differentiation has been shown to correlate with prognosis 
or biological behaviour in medulloblastomas. However, Provias and Becker commented that 
further progression of neuronal differentiation within the tumor might reduce the malignant 
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potential [11]. On the other hand, the 4-year survival rates reported by Packer et al for PNETs 
showing no evidence of cellular differentiation and PNETs with differentiation were reported 
to be 70% and 32%, respectively [12]. 
The exact mechanism of the extensive neuronal and glial maturation of medulloblastoma cells 
is unclear, but the repetitive surgical interventions, radiation and chemotherapy might have 
had certain cytostatic effects on rapidly dividing medulloblastoma cells, giving them a chance 
to mature into postmitotic cells with potential for neuronal and glial differentiation [2].  
In the light of all this scarce knowledge, it can be concluded that the glioblastoma presented in 
this report might be either a radiotherapy induced tumor or it may be derived from the S-
PNET or anaplastic ganglioglioma. Whatever the case, the existence of this dual pathology 
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